These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7757959)

  • 1. Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue.
    Catherino WH; Jordan VC
    Cancer Lett; 1995 May; 92(1):39-47. PubMed ID: 7757959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells.
    Barsalou A; Gao W; Anghel SI; Carrière J; Mader S
    J Biol Chem; 1998 Jul; 273(27):17138-46. PubMed ID: 9642281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line.
    Badia E; Duchesne MJ; Fournier-Bidoz S; Simar-Blanchet AE; Terouanne B; Nicolas JC; Pons M
    Cancer Res; 1994 Nov; 54(22):5860-6. PubMed ID: 7954415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.
    Sun J; Nawaz Z; Slingerland JM
    Mol Endocrinol; 2007 Nov; 21(11):2651-62. PubMed ID: 17666587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity.
    Fan JD; Wagner BL; McDonnell DP
    Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
    Catherino WH; Wolf DM; Jordan VC
    Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
    Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
    Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta.
    Watanabe T; Inoue S; Ogawa S; Ishii Y; Hiroi H; Ikeda K; Orimo A; Muramatsu M
    Biochem Biophys Res Commun; 1997 Jul; 236(1):140-5. PubMed ID: 9223441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
    Elgort MG; Zou A; Marschke KB; Allegretto EA
    Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.